HOB Biotech Group Corp.,Ltd (SHA:688656)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Allergy Detection Reagent	202.63M	-					170.24M	144.45M	109.74M
Autoimmune Reagents Products	145.94M	-					66.76M	46.25M	28.07M
Instrument Business	22.18M	-					14.04M	4.95M	4.92M
Others	18.44M	-					2.99M	2.37M	1.68M
Total	389.19M	-					254.03M	198.03M	144.41M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	377.21M	384.11M					-	-	-
Overseas	21.19M	18.23M					-	-	-
Total	398.40M	402.34M					-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error